These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

404 related items for PubMed ID: 17195626

  • 1. [Evaluation of residual immune response against human pox virus before and after revaccination in healthy volunteers].
    Bricaire F, Combadière B, Rouleau E, Bossi P, Garin D, Lebrun-Vignes B, Autran B.
    Bull Acad Natl Med; 2006; 190(4-5):1035-46; discussion 1046-9. PubMed ID: 17195626
    [Abstract] [Full Text] [Related]

  • 2. Bioterrorism. Smallpox vaccinations: how much protection remains?
    Cohen J.
    Science; 2001 Nov 02; 294(5544):985. PubMed ID: 11691969
    [No Abstract] [Full Text] [Related]

  • 3. Induction of human T cell-mediated immune responses after primary and secondary smallpox vaccination.
    Kennedy JS, Frey SE, Yan L, Rothman AL, Cruz J, Newman FK, Orphin L, Belshe RB, Ennis FA.
    J Infect Dis; 2004 Oct 01; 190(7):1286-94. PubMed ID: 15346340
    [Abstract] [Full Text] [Related]

  • 4. Age distribution for T cell reactivity to vaccinia virus in a healthy population.
    Hsieh SM, Pan SC, Chen SY, Huang PF, Chang SC.
    Clin Infect Dis; 2004 Jan 01; 38(1):86-9. PubMed ID: 14679452
    [Abstract] [Full Text] [Related]

  • 5. Real time PCR for the assessment of CD8+ T cellular immune response after prophylactic vaccinia vaccination.
    Trojan A, Rajeswaran R, Montemurro M, Mütsch M, Steffen R.
    J Clin Virol; 2007 Sep 01; 40(1):80-3. PubMed ID: 17644471
    [Abstract] [Full Text] [Related]

  • 6. Clinical and immunological responses to undiluted and diluted smallpox vaccine with vaccinia virus of Lister strain.
    Hsieh SM, Chen SY, Sheu GC, Hung MN, Chou WH, Chang SC, Hsu KH.
    Vaccine; 2006 Jan 23; 24(4):510-5. PubMed ID: 16139395
    [Abstract] [Full Text] [Related]

  • 7. Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans.
    Combadiere B, Boissonnas A, Carcelain G, Lefranc E, Samri A, Bricaire F, Debre P, Autran B.
    J Exp Med; 2004 Jun 07; 199(11):1585-93. PubMed ID: 15184506
    [Abstract] [Full Text] [Related]

  • 8. Primary induction of human CD8+ cytotoxic T lymphocytes and interferon-gamma-producing T cells after smallpox vaccination.
    Ennis FA, Cruz J, Demkowicz WE, Rothman AL, McClain DJ.
    J Infect Dis; 2002 Jun 01; 185(11):1657-9. PubMed ID: 12023773
    [Abstract] [Full Text] [Related]

  • 9. Smallpox vaccination and bioterrorism with pox viruses.
    Mayr A.
    Comp Immunol Microbiol Infect Dis; 2003 Oct 01; 26(5-6):423-30. PubMed ID: 12818626
    [Abstract] [Full Text] [Related]

  • 10. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination.
    Kim SH, Yeo SG, Park KH, Bang JW, Kim HB, Kim NJ, Jee Y, Cho H, Oh MD, Choe KW.
    Clin Microbiol Infect; 2007 Jan 01; 13(1):91-3. PubMed ID: 17184294
    [Abstract] [Full Text] [Related]

  • 11. Dose-related effects of smallpox vaccine.
    Frey SE, Newman FK, Cruz J, Shelton WB, Tennant JM, Polach T, Rothman AL, Kennedy JS, Wolff M, Belshe RB, Ennis FA.
    N Engl J Med; 2002 Apr 25; 346(17):1275-80. PubMed ID: 11923489
    [Abstract] [Full Text] [Related]

  • 12. Smallpox vaccination and the nurse.
    Clements TI.
    Kans Nurse; 2003 May 25; 78(5):5-7. PubMed ID: 12830676
    [No Abstract] [Full Text] [Related]

  • 13. [Development of a numerically additive combined vaccine against tetanus and smallpox].
    Mayr A, Baljer G, Wagner C, Sailer J.
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Apr 25; 259(2):206-18. PubMed ID: 2990123
    [Abstract] [Full Text] [Related]

  • 14. Ring vaccination versus mass vaccination in event of a smallpox attack.
    Lau CY, Wahl B, Foo WK.
    Hawaii Med J; 2005 Feb 25; 64(2):34-6, 53. PubMed ID: 15871566
    [Abstract] [Full Text] [Related]

  • 15. An update on smallpox vaccine candidates and their role in bioterrorism related vaccination strategies.
    Wiser I, Balicer RD, Cohen D.
    Vaccine; 2007 Jan 22; 25(6):976-84. PubMed ID: 17074424
    [Abstract] [Full Text] [Related]

  • 16. Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults.
    Treanor J, Wu H, Liang H, Topham DJ.
    Vaccine; 2006 Nov 17; 24(47-48):6913-23. PubMed ID: 17014939
    [Abstract] [Full Text] [Related]

  • 17. Addressing challenges for allergists in vaccination to protect against smallpox.
    Hackett CJ, Rotrosen D, Plaut M.
    Ann Allergy Asthma Immunol; 2005 Jan 17; 94(1):1-3. PubMed ID: 15702805
    [No Abstract] [Full Text] [Related]

  • 18. The nonreplicating smallpox candidate vaccines defective vaccinia Lister (dVV-L) and modified vaccinia Ankara (MVA) elicit robust long-term protection.
    Coulibaly S, Brühl P, Mayrhofer J, Schmid K, Gerencer M, Falkner FG.
    Virology; 2005 Oct 10; 341(1):91-101. PubMed ID: 16061267
    [Abstract] [Full Text] [Related]

  • 19. The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks.
    Handley L, Buller RM, Frey SE, Bellone C, Parker S.
    Expert Rev Vaccines; 2009 Jul 10; 8(7):841-50. PubMed ID: 19538111
    [Abstract] [Full Text] [Related]

  • 20. Smallpox and smallpox vaccination.
    Snyder KM.
    N Engl J Med; 2003 May 08; 348(19):1920-5; author reply 1920-5. PubMed ID: 12740964
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.